Revenue: The sum of all revenue fields included for a company's operating activities.
CRISPR Therapeutics AG (CRSP) had Revenue of $201.21M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$201.21M |
$89.35M |
|
-- |
|
$201.21M |
|
$131.62M |
|
$69.58M |
|
$20.00M |
|
$89.58M |
|
$89.58M |
|
$89.35M |
|
$89.35M |
|
$89.35M |
|
$89.35M |
|
$69.58M |
|
$74.48M |
|
79.22M |
|
79.22M |
|
$1.12 |
|
$1.12 |
|
| Balance Sheet Financials | |
$1.91B |
|
$151.94M |
|
$321.49M |
|
$2.23B |
|
$108.79M |
|
-- |
|
$237.98M |
|
$346.77M |
|
$1.88B |
|
$1.88B |
|
$1.88B |
|
80.04M |
|
| Cash Flow Statement Financials | |
$-260.38M |
|
$374.65M |
|
$62.66M |
|
$224.06M |
|
$401.07M |
|
$177.01M |
|
$81.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
34.58% |
|
34.58% |
|
-- |
|
44.52% |
|
44.41% |
|
$-269.85M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
1.01 |
|
89.46 |
|
4.75% |
|
4.75% |
|
4.01% |
|
4.75% |
|
$23.52 |
|
$-3.41 |
|
$-3.29 |
|